Stipple Bio Emerges From Stealth With Oversubscribed $100 Million Series A Financing To Advance STP-100 Into Early Clinical Studies And Advance A Precision Oncology Pipeline That Leverages Its Pointillist Platform
(MENAFN - GlobeNewsWire - Nasdaq) – Series A financing co-led by RA Capital, a16z Bio+Health and Nextech Invest, and includes participation from existing investors Emerson Collective Investments ...
Menafn
via Menafn
Updated 2h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
South Korea says 'credible intelligence' indicates North Korean leader's daughter is successor
Next


